David Grignon

1.3k total citations
26 papers, 965 citations indexed

About

David Grignon is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, David Grignon has authored 26 papers receiving a total of 965 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 11 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in David Grignon's work include Prostate Cancer Diagnosis and Treatment (10 papers), Prostate Cancer Treatment and Research (10 papers) and Bladder and Urothelial Cancer Treatments (7 papers). David Grignon is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (10 papers), Prostate Cancer Treatment and Research (10 papers) and Bladder and Urothelial Cancer Treatments (7 papers). David Grignon collaborates with scholars based in United States, Canada and Germany. David Grignon's co-authors include Mahul B. Amin, Kiril Trpkov, Antonio López-Beltrán, C.A. Lawton, William U. Shipley, R. L. Scotte Doggett, Muhyi Al‐Sarraf, Marvin Rotman, John M. Krall and Madhu J. John and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Oncogene.

In The Last Decade

David Grignon

24 papers receiving 931 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Grignon United States	12	669	283	214	156	113	26	965
Pam Unger United States	11	451 0.7×	83 0.3×	89 0.4×	123 0.8×	192 1.7×	17	682
Ignacio F. San Francisco Chile	16	588 0.9×	139 0.5×	188 0.9×	157 1.0×	10 0.1×	35	823
Piero De Carli Italy	15	209 0.3×	399 1.4×	24 0.1×	221 1.4×	24 0.2×	34	821
Muhammad Bulbul Lebanon	12	279 0.4×	212 0.7×	60 0.3×	101 0.6×	6 0.1×	52	481
Carlos E. Bermejo United States	12	154 0.2×	250 0.9×	106 0.5×	163 1.0×	7 0.1×	15	510
Marcus V. Sadi Brazil	10	426 0.6×	49 0.2×	85 0.4×	174 1.1×	6 0.1×	22	632
C. Radulescu France	16	355 0.5×	251 0.9×	45 0.2×	138 0.9×	5 0.0×	42	776
P C Walsh United States	9	485 0.7×	80 0.3×	71 0.3×	172 1.1×	7 0.1×	12	698
C. Cruickshank United Kingdom	6	123 0.2×	113 0.4×	50 0.2×	106 0.7×	27 0.2×	11	370
T Zwergel Germany	13	279 0.4×	88 0.3×	77 0.4×	245 1.6×	3 0.0×	36	553

Countries citing papers authored by David Grignon

Since Specialization

Citations

This map shows the geographic impact of David Grignon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Grignon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Grignon more than expected).

Fields of papers citing papers by David Grignon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Grignon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Grignon. The network helps show where David Grignon may publish in the future.

Co-authorship network of co-authors of David Grignon

This figure shows the co-authorship network connecting the top 25 collaborators of David Grignon. A scholar is included among the top collaborators of David Grignon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Grignon. David Grignon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Cañete‐Portillo, Sofía, Elsa F. Velázquez, Glen Kristiansen, et al.. (2020). Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers V. The American Journal of Surgical Pathology. 44(7). e80–e86. 18 indexed citations

2.

Perrino, Carmen M., John N. Eble, Chia‐Sui Kao, et al.. (2019). Plasmacytoid/diffuse urothelial carcinoma: a single-institution immunohistochemical and molecular study of 69 patients. Publisher. 1 indexed citations

3.

Perrino, Carmen M., John N. Eble, Chia‐Sui Kao, et al.. (2019). Plasmacytoid/diffuse urothelial carcinoma: a single-institution immunohistochemical and molecular study of 69 patients. Human Pathology. 90. 27–36. 30 indexed citations

4.

Grignon, David, et al.. (2019). Primary Renal Synovial Sarcomas: PAX 8 Immunostaining and Unusual Molecular Findings. Applied immunohistochemistry & molecular morphology. 28(3). 221–228. 12 indexed citations

5.

Shipley, William U., Stephanie L. Pugh, Himu Lukka, et al.. (2016). NRG Oncology/RTOG 9601, a phase III trial in prostate cancer patients: Anti-androgen therapy (AAT) with bicalutamide during and after salvage radiation therapy (RT) following radical prostatectomy (RP) and an elevated PSA.. Journal of Clinical Oncology. 34(2_suppl). 3–3. 9 indexed citations

6.

Lawton, C.A., James J. Dignam, G. Hanks, et al.. (2015). Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG Oncology/RTOG 9202. International Journal of Radiation Oncology*Biology*Physics. 93(3). S44–S44. 4 indexed citations

7.

Amin, Mahul B., Kiril Trpkov, Antonio López-Beltrán, & David Grignon. (2014). Best Practices Recommendations in the Application of Immunohistochemistry in the Bladder Lesions. The American Journal of Surgical Pathology. 38(8). e20–e34. 121 indexed citations

8.

Hunt, Dylan, David Grignon, Gerald E. Hanks, et al.. (2012). Gleason Pattern 5 is Associated With an Increased Risk for Metastasis Following Androgen Deprivation Therapy (ADT) and Radiation: An Analysis of RTOG 9202 and 9902. International Journal of Radiation Oncology*Biology*Physics. 84(3). S91–S92. 1 indexed citations

9.

Lawton, C., Michelle DeSilvio, W. Robert Lee, et al.. (2004). Results of a prospective multi-institutional phase II trial (RTOG 98–05) of transrectal ultrasound guided permanent radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate. International Journal of Radiation Oncology*Biology*Physics. 60. S184–S185. 1 indexed citations

10.

Lu, Jiandong, M.V. Pilepich, Sucha O. Asbell, et al.. (2001). Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials. Cancer/Radiothérapie. 5(2). 205–205. 4 indexed citations

11.

Tı́már, József, Erzsébet Rásó, Balázs Döme, et al.. (2000). Expression, subcellular localization and putative function of platelet-type 12-lipoxygenase in human prostate cancer cell lines of different metastatic potential. International Journal of Cancer. 87(1). 37–43. 69 indexed citations

12.

Powell, Isaac J., Mousumi Banerjee, Wael Sakr, et al.. (1999). Should African‐American men be tested for prostate carcinoma at an earlier age than white men?. Cancer. 85(2). 472–477.

13.

Tefilli, Marcos V., Edward L. Gheiler, Bijan Shekarriz, et al.. (1998). Primary adenocarcinoma of the urethra with metastasis to the glans penis: successful treatment with chemotherapy and radiation therapy. Urology. 52(3). 517–519. 6 indexed citations

14.

Pilepich, M.V., Kathryn Winter, Mack Roach, et al.. (1998). Phase III radiation therapy oncology group (RTOG) trial 86-10 od androgen deprivation before and during radiotherapy in locally advanced carcinoma of the prostate. International Journal of Radiation Oncology*Biology*Physics. 42(1). 177–177. 27 indexed citations

15.

Grignon, David, et al.. (1998). Incidence of Urethral Involvement in Female Bladder Cancer: An Anatomic Pathologic Study. The Journal of Urology. 160(5). 1956–1957. 2 indexed citations

16.

Shridhar, Viji, Liang Wang, Rita Rosati, et al.. (1997). Frequent breakpoints in the region surrounding FRA3B in sporadic renal cell carcinomas. Oncogene. 14(11). 1269–1277. 25 indexed citations

17.

Forman, Jeffrey D., et al.. (1996). 1006 Eearly termination of prostate cancer hyperfractionated dose escalation study. International Journal of Radiation Oncology*Biology*Physics. 36(1). 247–247. 1 indexed citations

18.

Pilepich, Miljenko V., William T. Sause, William U. Shipley, et al.. (1995). Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology group. Urology. 45(4). 616–623. 393 indexed citations

19.

Bostwick, David G., John R. Srigley, David Grignon, et al.. (1993). Atypical adenomatous hyperplasia of the prostate: Morphologic criteria for its distinction from well-differentiated carcinoma. Human Pathology. 24(8). 819–832. 163 indexed citations

20.

O’Malley, F P, et al.. (1991). Primary osteosarcoma of the kidney. Report of a case studied by immunohistochemistry, electron microscopy, and DNA flow cytometry.. PubMed. 115(12). 1262–5. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact